Emopamil

From WikiMD's WELLNESSPEDIA

Emopamil is a calcium channel blocker and sigma receptor ligand that has been studied for its potential use in the treatment of cardiovascular disease.

Pharmacology[edit]

Emopamil acts as a calcium channel blocker, inhibiting the influx of calcium ions into cardiac and smooth muscle cells. This action can lead to a decrease in blood pressure and a reduction in heart rate. Emopamil also has affinity for sigma receptors, which are thought to be involved in various physiological processes, including the regulation of neurotransmitter release.

Clinical Use[edit]

While emopamil has been studied for its potential use in the treatment of cardiovascular disease, it has not been approved for this use by any regulatory authority. The drug's effects on the cardiovascular system, including its ability to lower blood pressure and reduce heart rate, could potentially make it useful in the treatment of conditions such as hypertension and angina pectoris.

Side Effects[edit]

As with other calcium channel blockers, potential side effects of emopamil could include dizziness, headache, flushing, and edema. Due to its sigma receptor activity, emopamil could also potentially cause neurological side effects.

See Also[edit]


Emopamil gallery[edit]

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.